{"disease":{"id":"gvhd-graft-versus-host-disease","name":"gvhd graft versus host disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05263999","title":"A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":158,"lead_sponsor_name":"Equillium","has_results":false},{"nct_id":"NCT03894488","title":"Clinical Evaluation of the Application of the FilmArray GI Panel in Post-HSCT Diarrhea Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Shanghai Children's Medical Center","has_results":false},{"nct_id":"NCT06756061","title":"Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":88,"lead_sponsor_name":"Byung-Sik Cho","has_results":false},{"nct_id":"NCT03064984","title":"Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT06715046","title":"Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Turin, Italy","has_results":false},{"nct_id":"NCT02611180","title":"Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04745637","title":"Managed Access Programs for INC424, Ruxolitinib","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}